Cortical and raphe GABAA, AMPA receptors and glial GLT-1 glutamate transporter contribute to the sustained antidepressant activity of ketamine
Thu Ha Pham, Céline Defaix, Thi Mai Loan Nguyen, Indira Mendez‐David, Laurent Tritschler, Denis J. David, Alain M. Gardier
Topics & Concepts
NBQXAMPA receptorGlutamatergicKetamineNMDA receptorNeuroscienceGABAergicGlutamate receptorPharmacologyGABAA receptorBehavioural despair testInhibitory postsynaptic potentialAntidepressantChemistryPsychologyInternal medicineMedicineHippocampusReceptorTreatment of Major DepressionNeuroscience and Neuropharmacology ResearchTryptophan and brain disorders